Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

Aimaz Afrough; Hamza Hashmi; Doris K. Hansen; Surbhi Sidana; Chul Ahn; Lauren C. Peres; Danai Dima; Ciara L. Freeman; Omar Castaneda Puglianini; Mehmet H. Kocoglu; Shebli Atrash; Peter M. Voorhees; Leyla Shune; Joseph P. McGuirk; Gary Simmons; Douglas W. Sborov; James A. Davis; Gurbakhash Kaur; Aishwarya Sannareddy; Christopher J. Ferreri; Mahmoud R. Gaballa; Scott Goldsmith; Omar Nadeem; Shonali Midha; Charlotte B. Wagner; Frederick L. Locke; Krina K. Patel; Jack Khouri; Larry D. Anderson; Yi Lin

doi:10.1038/s41408-024-00993-0

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

Aimaz Afrough, Hamza Hashmi, Doris K. Hansen, Surbhi Sidana, Chul Ahn, Lauren C. Peres, Danai Dima, Ciara L. Freeman, Omar Castaneda Puglianini, Mehmet H. Kocoglu, Shebli Atrash, Peter M. Voorhees, Leyla Shune, Joseph P. McGuirk, Gary Simmons, Douglas W. Sborov, James A. Davis, Gurbakhash Kaur, Aishwarya Sannareddy, Christopher J. FerreriMahmoud R. Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B. Wagner, Frederick L. Locke, Krina K. Patel, Jack Khouri, Larry D. Anderson, Yi Lin

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Article number	63
Journal	Blood Cancer Journal
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41408-024-00993-0
State	Published - Dec 2024

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-024-00993-0

Cite this

Afrough, A., Hashmi, H., Hansen, D. K., Sidana, S., Ahn, C., Peres, L. C., Dima, D., Freeman, C. L., Puglianini, O. C., Kocoglu, M. H., Atrash, S., Voorhees, P. M., Shune, L., McGuirk, J. P., Simmons, G., Sborov, D. W., Davis, J. A., Kaur, G., Sannareddy, A., ... Lin, Y. (2024). Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Journal, 14(1), Article 63. https://doi.org/10.1038/s41408-024-00993-0

Afrough, A, Hashmi, H, Hansen, DK, Sidana, S, Ahn, C, Peres, LC, Dima, D, Freeman, CL, Puglianini, OC, Kocoglu, MH, Atrash, S, Voorhees, PM, Shune, L, McGuirk, JP, Simmons, G, Sborov, DW, Davis, JA, Kaur, G, Sannareddy, A, Ferreri, CJ, Gaballa, MR, Goldsmith, S, Nadeem, O, Midha, S, Wagner, CB, Locke, FL, Patel, KK, Khouri, J, Anderson, LD & Lin, Y 2024, 'Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium', Blood Cancer Journal, vol. 14, no. 1, 63. https://doi.org/10.1038/s41408-024-00993-0

@article{6e7872699b9849288d7eb47394f33ea7,

title = "Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium",

author = "Aimaz Afrough and Hamza Hashmi and Hansen, {Doris K.} and Surbhi Sidana and Chul Ahn and Peres, {Lauren C.} and Danai Dima and Freeman, {Ciara L.} and Puglianini, {Omar Castaneda} and Kocoglu, {Mehmet H.} and Shebli Atrash and Voorhees, {Peter M.} and Leyla Shune and McGuirk, {Joseph P.} and Gary Simmons and Sborov, {Douglas W.} and Davis, {James A.} and Gurbakhash Kaur and Aishwarya Sannareddy and Ferreri, {Christopher J.} and Gaballa, {Mahmoud R.} and Scott Goldsmith and Omar Nadeem and Shonali Midha and Wagner, {Charlotte B.} and Locke, {Frederick L.} and Patel, {Krina K.} and Jack Khouri and Anderson, {Larry D.} and Yi Lin",

year = "2024",

month = dec,

doi = "10.1038/s41408-024-00993-0",

language = "English (US)",

volume = "14",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

AU - Afrough, Aimaz

AU - Hashmi, Hamza

AU - Hansen, Doris K.

AU - Sidana, Surbhi

AU - Ahn, Chul

AU - Peres, Lauren C.

AU - Dima, Danai

AU - Freeman, Ciara L.

AU - Puglianini, Omar Castaneda

AU - Kocoglu, Mehmet H.

AU - Atrash, Shebli

AU - Voorhees, Peter M.

AU - Shune, Leyla

AU - McGuirk, Joseph P.

AU - Simmons, Gary

AU - Sborov, Douglas W.

AU - Davis, James A.

AU - Kaur, Gurbakhash

AU - Sannareddy, Aishwarya

AU - Ferreri, Christopher J.

AU - Gaballa, Mahmoud R.

AU - Goldsmith, Scott

AU - Nadeem, Omar

AU - Midha, Shonali

AU - Wagner, Charlotte B.

AU - Locke, Frederick L.

AU - Patel, Krina K.

AU - Khouri, Jack

AU - Anderson, Larry D.

AU - Lin, Yi

PY - 2024/12

Y1 - 2024/12

UR - http://www.scopus.com/inward/record.url?scp=85190285611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85190285611&partnerID=8YFLogxK

U2 - 10.1038/s41408-024-00993-0

DO - 10.1038/s41408-024-00993-0

M3 - Letter

C2 - 38609386

AN - SCOPUS:85190285611

SN - 2044-5385

VL - 14

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 1

M1 - 63

ER -

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this